RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Michael J Gonzalez to Antineoplastic Agents

This is a "connection" page, showing publications Michael J Gonzalez has written about Antineoplastic Agents.
Connection Strength

0.191
  1. Vaddula BR, Tantak MP, Sadana R, Gonzalez MA, Kumar D. One-pot synthesis and in-vitro anticancer evaluation of 5-(2'-indolyl)thiazoles. Sci Rep. 2016 Mar 29; 6:23401.
    View in: PubMed
    Score: 0.080
  2. Mateo J, Ong M, Tan DS, Gonzalez MA, de Bono JS. Appraising iniparib, the PARP inhibitor that never was--what must we learn? Nat Rev Clin Oncol. 2013 Dec; 10(12):688-96.
    View in: PubMed
    Score: 0.068
  3. Riordan HD, Riordan NH, Jackson JA, Casciari JJ, Hunninghake R, Gonz?lez MJ, Mora EM, Miranda-Massari JR, Rosario N, Rivera A. Intravenous vitamin C as a chemotherapy agent: a report on clinical cases. P R Health Sci J. 2004 Jun; 23(2):115-8.
    View in: PubMed
    Score: 0.035
  4. Riordan HD, Hunninghake RB, Riordan NH, Jackson JJ, Meng X, Taylor P, Casciari JJ, Gonz?lez MJ, Miranda-Massari JR, Mora EM, Rosario N, Rivera A. Intravenous ascorbic acid: protocol for its application and use. P R Health Sci J. 2003 Sep; 22(3):287-90.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support